Science:新型CD4 T细胞亚群调节肠道炎症反应

2016-06-06 佚名 生物谷

外周调节性T细胞(pTreg)对于限制由外源物质引起的炎症反应具有重要的作用。在肠道中,pTreg主要存在于固有层(lamina propria)中,而上皮间存在的CD4 T细胞同样具有抑制炎症反应的作用。这部分CD4 T细胞依赖视黄酸(Retinoic Acid)以及转化生长因子(TGF-b)发挥功能。为了研究肠道的炎症稳态调节过程中,pTreg以及CD4细胞分别发挥了怎样的作用,来自洛克

外周调节性T细胞(pTreg)对于限制由外源物质引起的炎症反应具有重要的作用。在肠道中,pTreg主要存在于固有层(lamina propria)中,而上皮间存在的CD4 T细胞同样具有抑制炎症反应的作用。这部分CD4 T细胞依赖视黄酸(Retinoic Acid)以及转化生长因子(TGF-b)发挥功能。为了研究肠道的炎症稳态调节过程中,pTreg以及CD4细胞分别发挥了怎样的作用,来自洛克菲勒大学的Daniel MucidaBernardo S. Reis课题组进行了深入研究,相关结果发表在最近的Science杂志上。

首先,作者利用双光子显微镜对小鼠肠道内的Treg细胞进行了动态追踪。结果显示,大部分Treg细胞分布于固有层(68%)以及肠道上皮层(14%)。剩下的18%Treg细胞虽然一直处于迁移的状态,但它们进入固有层的频率明显高于肠道上皮层。由于体外实验显示Treg在肠道上皮中的含量一直很低,这说明Treg细胞要么发生了凋亡,要么转变成其它类型的细胞。

虽然所有的Treg细胞都表达转录因子ThPOK,但小肠上皮层中的CD4T细胞中ThPOK的表达量却很低。 作者怀疑ThPOK的下调与CD4 T细胞的动态变化之间存在联系。它们利用OT-II小鼠进行试验,通过向这类小鼠进行OVA刺激,能够诱导其体内的T细胞下调ThPOK的表达。作者向全身性表达RFPOT-II小鼠体内转入ThPOK-GFP融合蛋白,再分选出天然的T细胞(RFP/GFP双阳性)打入Rag 1 ko小鼠体内,经过一周饲喂含有OVA的饲料后,作者追踪了这部分细胞并通过计算机进行了后续分析。结果显示,在经过OVA刺激后,打入的T细胞ThPOK的表达量明显下降。在那些ThPOK表达量仍较高的细胞群体中,仅有20%停留在小肠上皮层中。这说明在这一环境中,部分的T细胞要么下调了ThPOK的表达,要么发生了凋亡。

进一步,作者发现在小肠上皮中有相当一部分的Treg细胞FoxP3的表达量发生了明显的下调,它们转变为一种特殊的CD4 T细胞类型。

之后,作者发现这部分CD4 T细胞的数量在无菌小鼠中发生了明显的减少(约10倍)。通过抗生素处理,作者发现这一处理能够抑制TregFoxP3的下调,从而提高小肠上皮层中Treg细胞的数量。而ThPOK对于促进TregCD4 细胞的转化具有关键的作用。作者通过条件性敲除小鼠中的Treg细胞中的T-bet,发现这一转化效应出现了明显的降低,这说明Tet有可能通过下调ThPOK起到转变Treg表型的作用。

最终,作者证明了这部分特殊的上皮内的CD4 T细胞与组织适应性Treg细胞通过调节了肠道的炎症反应。

原始出处:

Sujino T, London M, Hoytema van Konijnenburg DP, Rendon T, Buch T, Silva HM, Lafaille JJ, Reis BS, Mucida D. Tissue adaptation of regulatory and intraepithelial CD4+ T cells controls gut inflammation. Science. 2016 Jun 2. pii: aaf3892.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1864211, encodeId=41a6186421118, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4325, encryptionId=f930432538, topicName=CD4)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Fri Nov 25 14:17:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320820, encodeId=e5c31320820ff, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Jun 08 04:17:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375264, encodeId=fc6213e5264e7, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Wed Jun 08 04:17:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414752, encodeId=8ebe1414e52d4, content=<a href='/topic/show?id=af1a8169e60' target=_blank style='color:#2F92EE;'>#肠道炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81697, encryptionId=af1a8169e60, topicName=肠道炎症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1f3086480, createdName=lancelotzzl, createdTime=Wed Jun 08 04:17:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88930, encodeId=f90688930b6, content=science精品啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Tue Jun 07 07:41:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88931, encodeId=503a889313e, content=值得研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Tue Jun 07 07:41:00 CST 2016, time=2016-06-07, status=1, ipAttribution=)]
    2016-11-25 qidongfanjian
  2. [GetPortalCommentsPageByObjectIdResponse(id=1864211, encodeId=41a6186421118, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4325, encryptionId=f930432538, topicName=CD4)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Fri Nov 25 14:17:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320820, encodeId=e5c31320820ff, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Jun 08 04:17:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375264, encodeId=fc6213e5264e7, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Wed Jun 08 04:17:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414752, encodeId=8ebe1414e52d4, content=<a href='/topic/show?id=af1a8169e60' target=_blank style='color:#2F92EE;'>#肠道炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81697, encryptionId=af1a8169e60, topicName=肠道炎症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1f3086480, createdName=lancelotzzl, createdTime=Wed Jun 08 04:17:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88930, encodeId=f90688930b6, content=science精品啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Tue Jun 07 07:41:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88931, encodeId=503a889313e, content=值得研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Tue Jun 07 07:41:00 CST 2016, time=2016-06-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1864211, encodeId=41a6186421118, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4325, encryptionId=f930432538, topicName=CD4)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Fri Nov 25 14:17:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320820, encodeId=e5c31320820ff, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Jun 08 04:17:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375264, encodeId=fc6213e5264e7, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Wed Jun 08 04:17:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414752, encodeId=8ebe1414e52d4, content=<a href='/topic/show?id=af1a8169e60' target=_blank style='color:#2F92EE;'>#肠道炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81697, encryptionId=af1a8169e60, topicName=肠道炎症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1f3086480, createdName=lancelotzzl, createdTime=Wed Jun 08 04:17:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88930, encodeId=f90688930b6, content=science精品啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Tue Jun 07 07:41:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88931, encodeId=503a889313e, content=值得研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Tue Jun 07 07:41:00 CST 2016, time=2016-06-07, status=1, ipAttribution=)]
    2016-06-08 jichang
  4. [GetPortalCommentsPageByObjectIdResponse(id=1864211, encodeId=41a6186421118, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4325, encryptionId=f930432538, topicName=CD4)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Fri Nov 25 14:17:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320820, encodeId=e5c31320820ff, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Jun 08 04:17:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375264, encodeId=fc6213e5264e7, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Wed Jun 08 04:17:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414752, encodeId=8ebe1414e52d4, content=<a href='/topic/show?id=af1a8169e60' target=_blank style='color:#2F92EE;'>#肠道炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81697, encryptionId=af1a8169e60, topicName=肠道炎症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1f3086480, createdName=lancelotzzl, createdTime=Wed Jun 08 04:17:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88930, encodeId=f90688930b6, content=science精品啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Tue Jun 07 07:41:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88931, encodeId=503a889313e, content=值得研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Tue Jun 07 07:41:00 CST 2016, time=2016-06-07, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1864211, encodeId=41a6186421118, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4325, encryptionId=f930432538, topicName=CD4)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Fri Nov 25 14:17:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320820, encodeId=e5c31320820ff, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Jun 08 04:17:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375264, encodeId=fc6213e5264e7, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Wed Jun 08 04:17:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414752, encodeId=8ebe1414e52d4, content=<a href='/topic/show?id=af1a8169e60' target=_blank style='color:#2F92EE;'>#肠道炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81697, encryptionId=af1a8169e60, topicName=肠道炎症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1f3086480, createdName=lancelotzzl, createdTime=Wed Jun 08 04:17:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88930, encodeId=f90688930b6, content=science精品啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Tue Jun 07 07:41:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88931, encodeId=503a889313e, content=值得研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Tue Jun 07 07:41:00 CST 2016, time=2016-06-07, status=1, ipAttribution=)]
    2016-06-07 milkshark

    science精品啊

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1864211, encodeId=41a6186421118, content=<a href='/topic/show?id=f930432538' target=_blank style='color:#2F92EE;'>#CD4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4325, encryptionId=f930432538, topicName=CD4)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Fri Nov 25 14:17:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320820, encodeId=e5c31320820ff, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Wed Jun 08 04:17:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1375264, encodeId=fc6213e5264e7, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Wed Jun 08 04:17:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414752, encodeId=8ebe1414e52d4, content=<a href='/topic/show?id=af1a8169e60' target=_blank style='color:#2F92EE;'>#肠道炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81697, encryptionId=af1a8169e60, topicName=肠道炎症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1f3086480, createdName=lancelotzzl, createdTime=Wed Jun 08 04:17:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88930, encodeId=f90688930b6, content=science精品啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Tue Jun 07 07:41:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88931, encodeId=503a889313e, content=值得研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Tue Jun 07 07:41:00 CST 2016, time=2016-06-07, status=1, ipAttribution=)]
    2016-06-07 milkshark

    值得研究

    0

相关资讯

Nature:揭示抗体进入神经系统控制病毒感染机制

在一项新的研究中,来自美国耶鲁大学医学院的研究人员解决了免疫系统的一个谜团---抗体如何进入神经系统控制病毒感染。他们的发现可能对预防和治疗一系列疾病---包括与寨卡病毒相关联的格林-巴利综合征(Guillain-Barre Syndrome)---产生影响。

Clin Trans Immunol:PD-1抗体能够激活抗原特异性T细胞免疫反应

特异性识别“检查点分子(checkpoint molecules)”的单克隆抗体目前正应用于治疗传染性疾病与癌症。对于患有传染性疾病与癌症的患者来说,体内正是缺少能够抵抗病毒或恶性肿瘤细胞的免疫反应。Anti-PD-1或PD-L1抗体主要是通过抑制PD-1信号通路,阻断免疫抑制效应,从而更大程度地激活针对病原体或肿瘤细胞的免疫反应。此前的实验结果表明:通过使用PD-1抗体,能够有效激活抗病毒

AIDS:HIV患者CD4细胞计数与缺血性卒中风险有关

一项为期15年的研究结果显示,HIV阳性的个体缺血性卒中的风险增高40%,但若此类个体CD4细胞计数增高,则相应风险与HIV阴性个体相似。 相关研究最近发表于国际AIDS学会官方杂志AIDS上。这项研究由1996年开始至2011年结束,涉及仅2.5万HIV阳性个体。缺血性卒中的发生是由于血管内斑块形成所致,可导致血管狭窄或堵塞,阻断脑部的血液和氧气供应。CD4细胞计数